<DOC>
	<DOC>NCT03025113</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of an association with one anti-inflammatory and one muscle relaxant agent compared to the one muscle relaxant agent isolated in the treatment of osteomuscular pain in adults.</brief_summary>
	<brief_title>Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine in Osteomuscular Treatment</brief_title>
	<detailed_description>- Double-blind, randomized, multicenter - Maximal experiment duration: 9 days - 02 or 03 visits and a phone contact - Evaluate the efficacy of an association with one anti-inflammatory and one muscle relaxant agent compared to the one muscle relaxant agent isolated in the treatment of osteomuscular pain in adults. - Adverse events evaluation</detailed_description>
	<mesh_term>Musculoskeletal Pain</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Cyclobenzaprine</mesh_term>
	<criteria>I Signed Consent of the patient; Participants presenting musculoskeletal pain, moderate or moderately severe, with VAS (visual analog scale) greater than 40 mm for a period of less than seven (7) days. Patients with any clinically significant disease that in the investigator is opinion can´t participate in the study; Patients with any laboratory finding or image finding that in the investigator is opinion can´t participate in the clinical trial; Patients with history of hypersensitivity to any of the formula compounds; Participation in clinical trial in the year prior to this study; Pregnancy or risk of pregnancy and lactating patients; Patients who were in use of drugs that can interfere with evaluation; History of with rheumatic diseases, fibromyalgia, osteoarticular diseases, dystonia, dystrophies and myopathies, acute infectious diseases, gastric duodenal ulcer or gastritis; Renal or hepatic impairment.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>